Translating today’s discoveries in childhood cancer research into tomorrow’s treatments.

Our strengths include cancer genomics, DNA damage, RNA biology and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.

Help us make a difference

Top stories

Manjeet Rao, Ph.D. in his lab

Greehey Deputy Director (interim), Manjeet Rao, Ph.D., Awarded NCI, R01 Grant to Test Efficacy of Novel Drug

UTHSA Presidential Award Image

Greehey CCRI Operations Mgr to Receive UT Heath SA 2020 Presidential Award

Jan 17 Molecular Cancer Research

Adam Kosti from Penalva Lab Publishes First, First-Author Paper

KENS5: David Libich, Ph.D. receives $306,000 St. Baldrick’s grant to study Ewing sarcoma.